Multiplex Assay Market By Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Cell-based Multiplex Assays), By Product (Reagents and Consumables, Instruments and Accessories, Software and Services), By Application (Clinical Diagnostics, Research and Development, Companion Diagnostics), By End User (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2023-2032
The Multiplex Assay Market was valued at $3.6 billion in 2022 and is estimated to reach $7.7 billion by 2032, exhibiting a CAGR of 7.8% from 2023 to 2032. Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, and chemokines) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in less time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, and forensic studies.
Major factors that drive the growth of the global multiplex assay market include rapid technological advancements in multiplex assay equipment, increase in R&D activities in pharmaceuticals for treatment of several diseases. These assays are used in clinical trials as they decrease the cost of research & manual labor and increase the efficiency of experiments and therapies. In addition, they offer easier & faster analysis of diseases and are automated as compared to conventional methods, which propels market growth.
However, high capital investments and dearth of skilled labors are the major factors that are expected to restrict the growth of the multiplex assay market. The high procurement and operational costs along with cumbersome and complex nature of multiplex assay instruments remain a key hurdle in the multiplex assay market. Moreover, increase in validation of biomarkers in molecular and protein diagnostics, along with rise in need of high-throughput and automated systems are anticipated to create lucrative opportunities for the expansion of the global market in the future. In addition, increase in funding for clinical research and drug discovery are expected to further propel the multiplex market growth.
The multiplex assay market is segmented on the basis of type, product, application, end user, and region. On the basis of type, the market is divided into protein based multiplex assay, nucleic acid-based multiplex assay, and cell-based multiplex assays. On the basis of product, the market is classified into reagents & consumables, instruments & accessories, and software & services. On the basis of application, the multiplex assay market is segregated into clinical diagnostics, research and development, and companion diagnostics. On the basis of end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnology companies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Abcam plc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A. (Luminex Corporation), Illumina Inc., Meso Scale Diagnostics LLC, QIAGEN N.V., Randox Laboratories Ltd., Seegene Inc., Thermo Fisher Scientific Inc. These major players have adopted acquisition, agreement, expansion, partnership, product launch, product approval as key developmental strategy to improve the product portfolio of the multiplex assay market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multiplex assay market analysis from 2022 to 2032 to identify the prevailing multiplex assay market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the multiplex assay market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global multiplex assay market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
Hospitals
Clinical Laboratories
Research Institutes
Pharmaceutical and Biotechnology Companies
By Type
Protein Based Multiplex Assays
Nucleic Acid-Based Multiplex Assays
Cell-based Multiplex Assays
By Product
Reagents and Consumables
Instruments and Accessories
Software and Services
By Application
Companion Diagnostics
Clinical Diagnostics
Research and Development
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Randox Laboratories Limited
Qiagen N.V
Seegene Inc
Thermo Fisher Scientific Inc.
Illumina Inc.
Bio-Rad Laboratories, Inc.
Abcam plc.
Becton, Dickinson and Company
MESO SCALE DIAGNOSTICS, LLC
Diasorin S.p.A.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of chronic disease
- 3.4.1.2. Rise in adoption of personalized medicines
- 3.4.1.3. Technological advancements in multiplexed products
- 3.4.2. Restraints
- 3.4.2.1. Lack of skilled labor/healthcare professionals
- 3.4.3. Opportunities
- 3.4.3.1. Rise in R&D activities
- CHAPTER 4: MULTIPLEX ASSAY MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Protein Based Multiplex Assays
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Nucleic Acid-Based Multiplex Assays
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Cell-based Multiplex Assays
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: MULTIPLEX ASSAY MARKET, BY PRODUCT
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Reagents and Consumables
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Instruments and Accessories
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Software and Services
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- CHAPTER 6: MULTIPLEX ASSAY MARKET, BY APPLICATION
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Clinical Diagnostics
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Research and Development
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Companion Diagnostics
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: MULTIPLEX ASSAY MARKET, BY END USER
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Hospitals
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Clinical Laboratories
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Research Institutes
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- 7.5. Pharmaceutical and Biotechnology Companies
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
- CHAPTER 8: MULTIPLEX ASSAY MARKET, BY REGION
- 8.1. Overview
- 8.1.1. Market size and forecast By Region
- 8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Type
- 8.2.3. Market size and forecast, by Product
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
- 8.2.6.1. U.S.
- 8.2.6.1.1. Market size and forecast, by Type
- 8.2.6.1.2. Market size and forecast, by Product
- 8.2.6.1.3. Market size and forecast, by Application
- 8.2.6.1.4. Market size and forecast, by End User
- 8.2.6.2. Canada
- 8.2.6.2.1. Market size and forecast, by Type
- 8.2.6.2.2. Market size and forecast, by Product
- 8.2.6.2.3. Market size and forecast, by Application
- 8.2.6.2.4. Market size and forecast, by End User
- 8.2.6.3. Mexico
- 8.2.6.3.1. Market size and forecast, by Type
- 8.2.6.3.2. Market size and forecast, by Product
- 8.2.6.3.3. Market size and forecast, by Application
- 8.2.6.3.4. Market size and forecast, by End User
- 8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Type
- 8.3.3. Market size and forecast, by Product
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
- 8.3.6.1. Germany
- 8.3.6.1.1. Market size and forecast, by Type
- 8.3.6.1.2. Market size and forecast, by Product
- 8.3.6.1.3. Market size and forecast, by Application
- 8.3.6.1.4. Market size and forecast, by End User
- 8.3.6.2. France
- 8.3.6.2.1. Market size and forecast, by Type
- 8.3.6.2.2. Market size and forecast, by Product
- 8.3.6.2.3. Market size and forecast, by Application
- 8.3.6.2.4. Market size and forecast, by End User
- 8.3.6.3. UK
- 8.3.6.3.1. Market size and forecast, by Type
- 8.3.6.3.2. Market size and forecast, by Product
- 8.3.6.3.3. Market size and forecast, by Application
- 8.3.6.3.4. Market size and forecast, by End User
- 8.3.6.4. Italy
- 8.3.6.4.1. Market size and forecast, by Type
- 8.3.6.4.2. Market size and forecast, by Product
- 8.3.6.4.3. Market size and forecast, by Application
- 8.3.6.4.4. Market size and forecast, by End User
- 8.3.6.5. Spain
- 8.3.6.5.1. Market size and forecast, by Type
- 8.3.6.5.2. Market size and forecast, by Product
- 8.3.6.5.3. Market size and forecast, by Application
- 8.3.6.5.4. Market size and forecast, by End User
- 8.3.6.6. Rest of Europe
- 8.3.6.6.1. Market size and forecast, by Type
- 8.3.6.6.2. Market size and forecast, by Product
- 8.3.6.6.3. Market size and forecast, by Application
- 8.3.6.6.4. Market size and forecast, by End User
- 8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Type
- 8.4.3. Market size and forecast, by Product
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
- 8.4.6.1. Japan
- 8.4.6.1.1. Market size and forecast, by Type
- 8.4.6.1.2. Market size and forecast, by Product
- 8.4.6.1.3. Market size and forecast, by Application
- 8.4.6.1.4. Market size and forecast, by End User
- 8.4.6.2. China
- 8.4.6.2.1. Market size and forecast, by Type
- 8.4.6.2.2. Market size and forecast, by Product
- 8.4.6.2.3. Market size and forecast, by Application
- 8.4.6.2.4. Market size and forecast, by End User
- 8.4.6.3. Australia
- 8.4.6.3.1. Market size and forecast, by Type
- 8.4.6.3.2. Market size and forecast, by Product
- 8.4.6.3.3. Market size and forecast, by Application
- 8.4.6.3.4. Market size and forecast, by End User
- 8.4.6.4. India
- 8.4.6.4.1. Market size and forecast, by Type
- 8.4.6.4.2. Market size and forecast, by Product
- 8.4.6.4.3. Market size and forecast, by Application
- 8.4.6.4.4. Market size and forecast, by End User
- 8.4.6.5. South Korea
- 8.4.6.5.1. Market size and forecast, by Type
- 8.4.6.5.2. Market size and forecast, by Product
- 8.4.6.5.3. Market size and forecast, by Application
- 8.4.6.5.4. Market size and forecast, by End User
- 8.4.6.6. Rest of Asia-Pacific
- 8.4.6.6.1. Market size and forecast, by Type
- 8.4.6.6.2. Market size and forecast, by Product
- 8.4.6.6.3. Market size and forecast, by Application
- 8.4.6.6.4. Market size and forecast, by End User
- 8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Type
- 8.5.3. Market size and forecast, by Product
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
- 8.5.6.1. Brazil
- 8.5.6.1.1. Market size and forecast, by Type
- 8.5.6.1.2. Market size and forecast, by Product
- 8.5.6.1.3. Market size and forecast, by Application
- 8.5.6.1.4. Market size and forecast, by End User
- 8.5.6.2. Saudi Arabia
- 8.5.6.2.1. Market size and forecast, by Type
- 8.5.6.2.2. Market size and forecast, by Product
- 8.5.6.2.3. Market size and forecast, by Application
- 8.5.6.2.4. Market size and forecast, by End User
- 8.5.6.3. South Africa
- 8.5.6.3.1. Market size and forecast, by Type
- 8.5.6.3.2. Market size and forecast, by Product
- 8.5.6.3.3. Market size and forecast, by Application
- 8.5.6.3.4. Market size and forecast, by End User
- 8.5.6.4. Rest of LAMEA
- 8.5.6.4.1. Market size and forecast, by Type
- 8.5.6.4.2. Market size and forecast, by Product
- 8.5.6.4.3. Market size and forecast, by Application
- 8.5.6.4.4. Market size and forecast, by End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product mapping of top 10 player
- 9.4. Competitive dashboard
- 9.5. Competitive heatmap
- 9.6. Top player positioning, 2022
- CHAPTER 10: COMPANY PROFILES
- 10.1. Thermo Fisher Scientific Inc.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.2. Illumina Inc.
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.3. Randox Laboratories Limited
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.4. Bio-Rad Laboratories, Inc.
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
- 10.5. Abcam plc.
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.6. Qiagen N.V
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.6.7. Key strategic moves and developments
- 10.7. Becton, Dickinson and Company
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
- 10.8. Seegene Inc
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
- 10.9. MESO SCALE DIAGNOSTICS, LLC
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.10. Diasorin S.p.A.
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- 10.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 02. MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. MULTIPLEX ASSAY MARKET FOR CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 06. MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. MULTIPLEX ASSAY MARKET FOR INSTRUMENTS AND ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. MULTIPLEX ASSAY MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 10. MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. GLOBAL MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 14. MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
- TABLE 15. MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 16. MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
- TABLE 17. MULTIPLEX ASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 18. MULTIPLEX ASSAY MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 19. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 20. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 21. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 22. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 24. U.S. MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 25. U.S. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 26. U.S. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 27. U.S. MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 28. CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 29. CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 30. CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 31. CANADA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 32. MEXICO MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 33. MEXICO MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 34. MEXICO MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. MEXICO MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 37. EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 38. EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 39. EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 40. EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 41. GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 42. GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 43. GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 44. GERMANY MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 45. FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 46. FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 47. FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 48. FRANCE MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 49. UK MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 50. UK MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 51. UK MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 52. UK MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 53. ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 54. ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 55. ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 56. ITALY MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 57. SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 58. SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 59. SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 60. SPAIN MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 61. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 62. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 63. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 64. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 65. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 66. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 67. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 68. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 69. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 70. JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 71. JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 72. JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 73. JAPAN MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 74. CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 75. CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 76. CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 77. CHINA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 78. AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 79. AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 80. AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 81. AUSTRALIA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 82. INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 83. INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 84. INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 85. INDIA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 86. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 87. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 88. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 89. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 90. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 91. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 92. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 93. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 94. LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 95. LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 96. LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 97. LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 98. LAMEA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 99. BRAZIL MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 100. BRAZIL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 101. BRAZIL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 102. BRAZIL MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 103. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 104. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 105. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 106. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 107. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 108. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 109. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 110. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 111. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 112. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 113. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 114. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 115. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
- TABLE 116. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
- TABLE 117. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
- TABLE 118. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
- TABLE 119. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
- TABLE 120. ILLUMINA INC.: KEY EXECUTIVES
- TABLE 121. ILLUMINA INC.: COMPANY SNAPSHOT
- TABLE 122. ILLUMINA INC.: PRODUCT SEGMENTS
- TABLE 123. ILLUMINA INC.: PRODUCT PORTFOLIO
- TABLE 124. RANDOX LABORATORIES LIMITED: KEY EXECUTIVES
- TABLE 125. RANDOX LABORATORIES LIMITED: COMPANY SNAPSHOT
- TABLE 126. RANDOX LABORATORIES LIMITED: PRODUCT SEGMENTS
- TABLE 127. RANDOX LABORATORIES LIMITED: PRODUCT PORTFOLIO
- TABLE 128. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
- TABLE 129. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
- TABLE 130. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
- TABLE 131. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
- TABLE 132. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
- TABLE 133. ABCAM PLC.: KEY EXECUTIVES
- TABLE 134. ABCAM PLC.: COMPANY SNAPSHOT
- TABLE 135. ABCAM PLC.: PRODUCT SEGMENTS
- TABLE 136. ABCAM PLC.: PRODUCT PORTFOLIO
- TABLE 137. QIAGEN N.V: KEY EXECUTIVES
- TABLE 138. QIAGEN N.V: COMPANY SNAPSHOT
- TABLE 139. QIAGEN N.V: PRODUCT SEGMENTS
- TABLE 140. QIAGEN N.V: PRODUCT PORTFOLIO
- TABLE 141. QIAGEN N.V: KEY STRATERGIES
- TABLE 142. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 143. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 144. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
- TABLE 145. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 146. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
- TABLE 147. SEEGENE INC: KEY EXECUTIVES
- TABLE 148. SEEGENE INC: COMPANY SNAPSHOT
- TABLE 149. SEEGENE INC: PRODUCT SEGMENTS
- TABLE 150. SEEGENE INC: PRODUCT PORTFOLIO
- TABLE 151. SEEGENE INC: KEY STRATERGIES
- TABLE 152. MESO SCALE DIAGNOSTICS, LLC: KEY EXECUTIVES
- TABLE 153. MESO SCALE DIAGNOSTICS, LLC: COMPANY SNAPSHOT
- TABLE 154. MESO SCALE DIAGNOSTICS, LLC: PRODUCT SEGMENTS
- TABLE 155. MESO SCALE DIAGNOSTICS, LLC: PRODUCT PORTFOLIO
- TABLE 156. DIASORIN S.P.A.: KEY EXECUTIVES
- TABLE 157. DIASORIN S.P.A.: COMPANY SNAPSHOT
- TABLE 158. DIASORIN S.P.A.: PRODUCT SEGMENTS
- TABLE 159. DIASORIN S.P.A.: PRODUCT PORTFOLIO
- TABLE 160. DIASORIN S.P.A.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. MULTIPLEX ASSAY MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF MULTIPLEX ASSAY MARKET,2022-2032
- FIGURE 03. TOP IMPACTING FACTORS IN MULTIPLEX ASSAY MARKET (2022 TO 2032)
- FIGURE 04. TOP INVESTMENT POCKETS IN MULTIPLEX ASSAY MARKET (2023-2032)
- FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 06. LOW THREAT OF NEW ENTRANTS
- FIGURE 07. LOW THREAT OF SUBSTITUTES
- FIGURE 08. LOW INTENSITY OF RIVALRY
- FIGURE 09. LOW BARGAINING POWER OF BUYERS
- FIGURE 10. GLOBAL MULTIPLEX ASSAY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11. MULTIPLEX ASSAY MARKET, BY TYPE, 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CELL-BASED MULTIPLEX ASSAYS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 15. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR INSTRUMENTS AND ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 23. MULTIPLEX ASSAY MARKET, BY END USER, 2022 AND 2032(%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 26. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 27. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 28. MULTIPLEX ASSAY MARKET BY REGION, 2022 AND 2032(%)
- FIGURE 29. U.S. MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 30. CANADA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 31. MEXICO MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 32. GERMANY MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 33. FRANCE MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 34. UK MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 35. ITALY MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 36. SPAIN MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 37. REST OF EUROPE MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 38. JAPAN MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 39. CHINA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 40. AUSTRALIA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 41. INDIA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 42. SOUTH KOREA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 43. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 44. BRAZIL MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 45. SAUDI ARABIA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 46. SOUTH AFRICA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 47. REST OF LAMEA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
- FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49. COMPETITIVE DASHBOARD
- FIGURE 50. COMPETITIVE HEATMAP: MULTIPLEX ASSAY MARKET
- FIGURE 51. TOP PLAYER POSITIONING, 2022
- FIGURE 52. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 53. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 54. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 55. ILLUMINA INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 56. ILLUMINA INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 57. ILLUMINA INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 58. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
- FIGURE 59. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 60. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 61. ABCAM PLC.: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 62. ABCAM PLC.: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 63. QIAGEN N.V: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 64. QIAGEN N.V: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 65. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 66. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 67. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 68. SEEGENE INC: NET SALES, 2019-2021 ($MILLION)
- FIGURE 69. SEEGENE INC: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 70. DIASORIN S.P.A.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 71. DIASORIN S.P.A.: REVENUE SHARE BY REGION, 2021 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook